CPT code 0482U: Preeclampsia assay, serum ratio, two-week risk2026 Medicare lab fee · Clinical Laboratory Fee Schedule

This serum assay reports an sFlt-1/PlGF ratio to assess risk of progression to preeclampsia with severe features within two weeks.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $128.82 for 0482U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$128.82

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2025
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 7 sections
  1. Medicare lab fee
  2. What 0482U covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Billing questions
  7. Sources

What 0482U covers

0482U describes an obstetric biochemical assay of serum soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF), with an sFlt-1/PlGF ratio used to assess risk of progression to preeclampsia with severe features within two weeks. Obstetric clinicians, including maternal-fetal medicine specialists, may use the result when assessing a pregnant patient for preeclampsia. A clinical laboratory performs the assay and reports the result to the ordering clinician.

Medicare pays 0482U through the CLFS at one national amount, with no locality or office-versus-facility difference. The 2026 national CLFS amount is $128.82, unchanged from 2025. The physician fee schedule has no separate payment row for this code.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 0482U

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 0482U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Not on the physician fee schedule

The physician fee schedule doesn’t list 0482U: Medicare pays the test only from the CLFS.

0482U on the lab fee schedule since 2024

0482U · CLFS 2026 Q4 (current)

$128.82

Unchanged since Jan 1, 2025

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Jan 1, 2025 · CLFS 2025 Q1MAC-priced → $128.82

9 quarterly CLFS releases on file, first CLFS 2024 Q4. A code missing from a quarter wasn’t on that release.

0482U compared with similar tests

0488UFetal antigen testCell-free DNA, selected antigens$759.05
0488U describes an obstetric fetal-antigen cfDNA analysis. 0482U measures serum sFlt-1 and PlGF and reports a ratio for preeclampsia progression risk.
0489UPrenatal cfDNA testSingle-gene fetal risk score$1,153.62
0489U describes an obstetric single-gene cfDNA sequencing analysis. It is distinct from 0482U, which reports a serum sFlt-1/PlGF ratio for preeclampsia progression risk.

0482U billing questions

What does the assay measure?

It measures serum sFlt-1 and PlGF and reports their ratio to assess risk of progression to preeclampsia with severe features within two weeks.

What specimen does the assay use?

The assay uses serum.

Does 0482U describe one factor or both?

It describes an assay measuring both sFlt-1 and PlGF and reporting their ratio.

How does 0482U differ from obstetric cfDNA codes?

0482U is a serum protein-and-factor ratio assay for preeclampsia progression risk. Codes 0488U and 0489U describe obstetric cfDNA analyses.

Does Medicare pay a separate physician interpretation for this code?

0482U is paid through the CLFS, and there is no separate physician fee schedule payment row for the code.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 0482UPUF_CLFS_CY2026_Q4V1.csv, line 430 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 0482U?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 0482U and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist